Pages that link to "Q73133107"

The following pages link to Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules (Q73133107):

Displaying 18 items.

• Effect of substituting IPV for tOPV on immunity to poliovirus in Bangladeshi infants: An open-label randomized controlled trial (Q30277951) (← links)
• Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge (Q34244892) (← links)
• Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial. (Q36279108) (← links)
• The final stages of the global eradication of poliomyelitis (Q37037388) (← links)
• Oral and inactivated poliovirus vaccines in the newborn: a review (Q37164542) (← links)
• Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission (Q37928163) (← links)
• Expert review on poliovirus immunity and transmission (Q38026922) (← links)
• Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa (Q38039615) (← links)
• Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. (Q38544598) (← links)
• Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial (Q42206358) (← links)
• Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay (Q42413057) (← links)
• Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. (Q43955421) (← links)
• Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial (Q51783086) (← links)
• Professor Natan Goldblum and the Combined Vaccination Program in Gaza (Q52346795) (← links)
• Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame (Q58094225) (← links)
• Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial (Q64127075) (← links)
• Controversies in polio immunization (Q73858809) (← links)
• Effectiveness of inactivated poliovirus vaccine (Q79715511) (← links)